Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001220110 | SCV001392083 | pathogenic | Hereditary spastic paraplegia 48 | 2022-09-07 | criteria provided, single submitter | clinical testing | ClinVar contains an entry for this variant (Variation ID: 948785). For these reasons, this variant has been classified as Pathogenic. This premature translational stop signal has been observed in individual(s) with complicated spastic paraplegia (PMID: 27606357). This variant is present in population databases (rs762066700, gnomAD 0.01%). This sequence change creates a premature translational stop signal (p.Arg345*) in the AP5Z1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in AP5Z1 are known to be pathogenic (PMID: 20613862, 27606357). |
Genome Diagnostics Laboratory, |
RCV001847197 | SCV002106050 | pathogenic | Hereditary spastic paraplegia | 2021-07-09 | criteria provided, single submitter | clinical testing | |
Centre for Clinical Genetics and Genomic Diagnostics, |
RCV004720800 | SCV005328405 | pathogenic | not provided | 2023-06-15 | criteria provided, single submitter | clinical testing | Found in putative compoúnd heterozygous state with another AP5Z1 variant. |